FACT (DAP) — Ministry Approval for DAP Production

FACT (Fertilizers and Chemicals Travancore Limited) Announcement Overview – April 7, 2026

On April 7, 2026, FACT announced key regulatory and operational updates:

Key Announcements from April 7, 2026

Ministry of Chemicals and Fertilizers Approval for DAP Production

- FACT received approval from India’s Ministry of Chemicals and Fertilizers to manufacture di-ammonium phosphate (DAP) at its Udyogmandal plant under the NBS (Nehru-Bhagwan) scheme.

- This expansion is subject to final approvals and compliance with conditions set by the ministry.

> This development aligns with FACT’s strategic push to diversify its fertilizer portfolio and capitalize on domestic demand for phosphatic fertilizers.

Leadership Changes

- Shri Anupam Misra stepped down as Director (Marketing) effective July 1, 2026, following regulatory compliance with SEBI Listing Obligations. His resignation was confirmed on July 1, 2026.

- Shri Niranjan Suryabhan Sonak was appointed as Additional Director (Marketing) for a provisional period of up to three months, pending approval from the Apex Committee on Company Affairs (ACC). This appointment took effect on July 6, 2026.

> These changes reflect internal restructuring amid ongoing operational challenges.

Context & Implications

Strategic Move Toward DAP Production

- The approval to produce DAP signals FACT’s intent to strengthen its position in the phosphatic fertilizer market, which is critical for crops like rice, wheat, and pulses.

- DAP is a high-demand fertilizer, especially with India’s focus on food security and agricultural productivity.

Leadership Transition

- The exit of Anupam Misra and interim appointment of Niranjan Sonak suggest a short-term focus on stabilizing marketing operations while the board searches for a permanent replacement.

- The ACC’s final approval remains a key milestone for the new director’s role.

Recent Financial Performance (as of Q4 FY26)

Metric	FY26 (₹ Cr)	FY25 (₹ Cr)	Change
Revenue	5,723.76	4,050.91	+41.3%
Net Loss	396.0	412.3	-3.9%
EPS (Diluted)	-₹0.61	₹0.64	-195.3%
Operating Income	-51.45	31.76	-262.3%

Despite higher revenue, FACT continued to grapple with operational inefficiencies and joint venture losses, resulting in a net loss for FY26.

Investor Considerations

DAP Expansion: Positive long-term catalyst if approvals are secured; could boost margins and market share.

Leadership Vacuum: Short-term uncertainty in marketing strategy until a permanent director is appointed.

Financial Health: Improved top-line growth but ongoing losses highlight need for cost optimization and asset restructuring.

Next Steps to Watch:

- ACC approval for Niranjan Sonak’s directorship.

- Progress on DAP production commissioning at Udyogmandal.

- Q1 FY27 earnings (due July 27, 2026) for early signs of margin improvement.

🔍 For Deep Analysis (click below):

How will the DAP expansion impact FACT’s capacity utilization and gross margins in FY27?

What are the key risks associated with the ongoing JV insolvency and discontinuation of FRBL consolidation?

How does FACT’s valuation compare to peers like Coromandel International and Chambal Fertilizers post this announcement?

📊 Stock Analysis — DAP ✨ Ask AI About DAP

More About DAP

Related Insights

📡 Get AI alerts for your stocks — summarized by AI daily

Set up your AI Radar — pick stocks, get daily email summaries of new filings.

Set up AI Radar — Free

Free account · 2 AI queries/day